Ivonescimab Plus Chemotherapy in Patients With EGFR Variant Non-Small Cell Lung Cancer

被引：0
|
作者：
Liu, Zaoqu [1 ]
Shan, Dan [2 ]
Han, Xinwei [3 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Basic Med Sci, Beijing, Peoples R China
[2] Univ Hosp Galway, Clin Sci Inst, Galway, Ireland
[3] Zhengzhou Univ, Affiliated Hosp 1, Dept Intervent Radiol, Zhengzhou, Peoples R China
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2025年 / 333卷 / 02期
关键词：
D O I：
10.1001/jama.2024.23091
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non-small cell lung cancer
    Feldman, Hope
    Sepesi, Boris
    Leung, Cheuk H.
    Lin, Heather
    Weissferdt, Annikka
    Pataer, Apar
    William Jr, William N.
    Walsh, Garrett L.
    Rice, David C.
    Roth, Jack A.
    Mehran, Reza J.
    Hofstetter, Wayne L.
    Antonoff, Mara B.
    Rajaram, Ravi
    Gibbons, Don L.
    Lee, J. Jack
    Heymach, John V.
    Vaporciyan, Ara A.
    Swisher, Stephen G.
    Cascone, Tina
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2024, 167 (04):
  • [22] Amivantamab with chemotherapy - Non-small cell lung cancer with EGFR exon 20 insertions
    Drappier, Noemie
    Pierret, Thomas
    BULLETIN DU CANCER, 2024, 111 (12) : 1085 - 1087
  • [23] Bevacizumab in combination with chemotherapy for treating patients with advanced RET plus non-small cell lung cancer
    Aldea, Mihaela
    Marinello, Arianna
    Monnet, Isabelle
    de Saint Basile, Hortense
    Cousin, Sophie
    Duruisseaux, Michael
    Calles, Antonio
    Metro, Giulio
    Zugazagoitia, Jon
    Massa, Giacomo
    Gomez, Patricia
    Tabbo, Fabrizio
    Russo, Alessandro
    Fallet, Vincent
    Lindsay, Colin R.
    Bria, Emilio
    Eisert, Anna
    Guisier, Florian
    Planchard, David
    Besse, Benjamin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [24] Re-challenge chemotherapy with gemcitabine plus carboplatin in patients with non-small cell lung cancer
    Khurum Khan
    Gerard G Hanna
    Lynn Campbell
    Paula Scullin
    Adnan Hussain
    Ruth L Eakin
    Jonathan McAleese
    Chinese Journal of Cancer, 2013, 32 (10) : 539 - 545
  • [25] Re-challenge chemotherapy with gemcitabine plus carboplatin in patients with non-small cell lung cancer
    Khan, Khurum
    Hanna, Gerard G.
    Campbell, Lynn
    Scullin, Paula
    Hussain, Adnan
    Eakin, Ruth L.
    McAleese, Jonathan
    CHINESE JOURNAL OF CANCER, 2013, 32 (10) : 539 - 545
  • [26] Integrated chemotherapy with EGFR receptor tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring EGFR mutation
    Maevskaya, J.
    Laktionov, K.
    Yudin, D.
    Vladimirova, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S1402 - S1402
  • [27] Chemotherapy in the management of patients with inoperable non-small cell lung cancer
    Carney, DN
    SEMINARS IN ONCOLOGY, 1996, 23 (06) : 71 - 75
  • [28] Tislelizumab plus chemotherapy for patients with EGFR-mutated non-squamous non-small cell lung cancer who progressed on EGFR tyrosine kinase inhibitor therapy
    Zhong, Hua
    Zhang, Xueyan
    Tian, Panwen
    Chu, Tianqing
    Guo, Qisen
    Yu, Xinmin
    Yu, Zhuang
    Li, Yalun
    Chen, Lijuan
    Liu, Jie
    Zhang, Yan
    Guan, Yan
    Shi, Xun
    Wang, Jing
    Zhao, Yanqiu
    Han, Baohui
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (08)
  • [29] Optimizing chemotherapy for patients with advanced non-small cell lung cancer
    Scagliotti, Giorgio
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (06) : S86 - S91
  • [30] Predicting the response to chemotherapy in patients with non-small cell lung cancer
    Wislez, M.
    Antoine, M.
    Lavole, A.
    Gounant, V.
    Milleron, B.
    Cadranel, J.
    REVUE DES MALADIES RESPIRATOIRES, 2007, 24 (08) : S206 - S210
12345